Atherosclerosis & Thrombotic Disease in Rheumatic Conditions Staff | March 29, 2021 Review our article: "Bloody Important: Atherosclerosis & Thrombotic Disease in Rheumatic Conditions," October 2020. Cardiovascular conditions, such as atherosclerosis and venous thromboembolic disease, can be influenced by inflammatory activity, and treatment of rheumatologic conditions may play a role in increasing or decreasing the risks of such diseases. Which of the following treatments may protect patients with a rheumatic condition from a cardiovascular event? A. Methotrexate B. Tumor necrosis factor inhibitors C. Janus kinase (JAK) inhibitors D. Canakinumab, an IL-1β inhibitor None Time's up
